# Pro-Angiogenic Bioactive Molecules in Vascular Morphogenesis: Integrating Endothelial Cell Dynamics

**Authors:** Claudiu N. Lungu, Gabriela Gurau, Mihaela C. Mehedinti

PMC · DOI: 10.3390/cimb47100851 · Current Issues in Molecular Biology · 2025-10-15

## TL;DR

This review explores how bioactive molecules and cellular chirality influence blood vessel formation during development and how these mechanisms could aid in creating replacement vascular tissue.

## Contribution

The paper highlights the role of cellular chirality and VEGF/VEGFR signaling in vascular morphogenesis and their implications for therapeutic applications.

## Key findings

- Cellular chirality is essential for directing endothelial cell organization during angiogenesis.
- VEGFR2 is a central player in vascular morphogenesis, regulated by VEGF ligands.
- Molecular pathways and mechanical factors influence vascular stabilization and helical vasculogenesis.

## Abstract

During embryonic development, angiogenesis and arteriogenesis are responsible for vast growth and remodeling. These processes have distinct mechanisms, like budding, cord hollowing, cell hollowing, cell wrapping, and intussusception. This review discusses the diversity of morphogenetic mechanisms contributing to vessel assembly and angiogenic sprouting in blood vessels and how molecular pathways regulate some complex cell behaviors concerning the VEGFR pathway. Also, a particular part is dedicated to the HIF 1α gene. The key components of the VEGFR pathway are VEGF receptors VEGFR1, VEGFR2, and VEGFR3. VEGFR2 plays a central role in vascular morphogenesis. VEGF is the primary ligand involved in angiogenesis and arteriogenesis. Various types of VEGF are being studied in terms of their therapeutic use. The ultimate goal of the vascular morphogenesis study is to enable the development of organized vascular tissue that presumably might be used to replace the diseased one. Cellular chirality—the intrinsic “handedness” of cells in movement, structure, and organization—plays a crucial role in angiogenesis, the process by which new blood vessels develop from old ones. This chiral activity is essential for the directed and patterned organization of endothelial cells during vascular formation and remodeling. In angiogenesis, cellular chirality directs endothelial cells to adopt specific orientations and migratory patterns, which are crucial for the formation of functionally organized blood vessels that provide tissues with the necessary nutrients and oxygen. Cellular chirality in this environment is affected by multiple mechanisms, including VEGF/VEGFR signaling, mechanical pressures, interactions with the extracellular matrix (ECM), and cytoskeletal movements. Lately, researchers have focused on the molecular control of blood vessel morphogenesis, the study of signaling circuitry implied in vascular morphogenesis, the emerging mechanism of vascular stabilization, and helical vasculogenesis driven by cell chirality.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321], KDR (kinase insert domain receptor) [NCBI Gene 3791], FLT4 (fms related receptor tyrosine kinase 4) [NCBI Gene 2324]

## Full-text entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, FLT4 (fms related receptor tyrosine kinase 4) [NCBI Gene 2324] {aka CHTD7, FLT-4, FLT41, LMPH1A, LMPHM1, PCL}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}
- **Chemicals:** oxygen (MESH:D010100)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12564000/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12564000/full.md

## References

283 references — full list in the complete paper: https://tomesphere.com/paper/PMC12564000/full.md

---
Source: https://tomesphere.com/paper/PMC12564000